Showing results (191-200 of 265) with videos related to
Sort By:
Pageof 27
Blood|June 15, 1996
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemiaJ Brisco, E Hughes, S H Neoh, et al.Bone Marrow Transplantation|May 1, 2007
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantationM A Slavin, A P Grigg, A P Schwarer, et al.Journal of Nutritional Science and Vitaminology|January 1, 1992
G-CSF mobilised progenitor cells in autologous transplantation: in vitro and in vivo aspectsC G Begley, E DeLuca, P A Rowlings, et al.Internal Medicine Journal|August 12, 2011
How we mobilize haemopoietic stem cellsK E Herbert, J-P Levesque, A K Mills, et al.Blood|September 1, 1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2J C Biggs, J Szer, P Crilley, et al.Experimental Hematology|November 7, 2000
Adaptor protein SKAP55R is associated with myeloid differentiation and growth arrestD J Curtis, S M Jane, D J Hilton, et al.AJR. American Journal of Roentgenology|April 1, 1984
Importance of soft-tissue evaluation in hand and wrist trauma: statistical evaluationD J Curtis, E F Downey, A C Brower, et al.Bone Marrow Transplantation|January 1, 1995
Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study GroupJ C Biggs, K A Atkinson, V Booker, et al.Bone Marrow Transplantation|March 7, 2006
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateN Murphy, M Diviney, J Szer, et al.Internal Medicine Journal|December 9, 2014
Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014M A Slavin, K A Thursky, L J Worth, et al.Pageof 27